MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Cited by (1,007)

Items 101–200 of 1,007

1. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression
   Ding, Yixuan, Cao, Feng, Sun, Haichen, Wang, Yecheng, Liu, Shuang, Wu, Yanchuan, Cui, Qingye, Mei, WenTong, Li, Fei · 2019 · Cancer Letters
2. The Role of MicroRNAs in Hepatocellular Carcinoma
   Xin Xu, Yuquan Tao, Liang Shan, Rui Chen, Hongyuan Jiang, Zijun Qian, Feng Cai, Lifang Ma, Yongchun Yu · 2018 · Journal of Cancer
3. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy
   Yazhe Wang, Ying Xie, Kameron V. Kilchrist, Jing Li, Craig L. Duvall, David Oupický · 2020 · ACS Applied Materials & Interfaces
4. RETRACTED: Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway
   Dongwei Dou, Xiaoyang Ren, Mingli Han, Xiaodong Xu, Xin Ge, Yuanting Gu, Xinxing Wang · 2020 · Frontiers in Immunology · Retracted
5. Anticancer property of ginsenoside Rh2 from ginseng
   Xun Li, Shifeng Chu, Meiyu Lin, Yan Gao, Yingjiao Liu, Songwei Yang, Xin‐Fu Zhou, Yani Zhang, Yaomei Hu, Huiqin Wang et al. · 2020 · European Journal of Medicinal Chemistry
6. A Tetrahedral Framework DNA‐Based Bioswitchable miRNA Inhibitor Delivery System: Application to Skin Anti‐Aging
   Songhang Li, Yuhao Liu, Tao Zhang, Shiyu Lin, Sirong Shi, Jiajun He, Yu Xie, Xiaoxiao Cai, Taoran Tian, Yunfeng Lin · 2022 · Advanced Materials
7. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer
   Xin Lai, Martin Eberhardt, Ulf Schmitz, Julio Vera · 2019 · Nucleic Acids Research
8. RNA Nanotechnology-Mediated Cancer Immunotherapy
   Yao‐Xin Lin, Yi Wang, Sara Blake, Mian Yu, Lin Mei, Hao Wang, Jinjun Shi · 2019 · Theranostics
9. RNA sequencing data integration reveals an miRNA interactome of osteoarthritis cartilage
   Rodrigo Coutinho de Almeida, Y.F. Ramos, Ahmed Essam Mahfouz, Wouter den Hollander, Nico Lakenberg, Evelyn Houtman, Marcella van Hoolwerff, H. Eka D. Suchiman, Alejandro Rodríguez Ruiz, P. Eline Slagboom et al. · 2019 · Annals of the Rheumatic Diseases
10. Non-coding RNAs and ferroptosis: potential implications for cancer therapy
    Amar Balihodzic, Felix Prinz, Michael A. Dengler, George A. Călin, Philipp Jakob Jost, Martin Pichler · 2022 · Cell Death and Differentiation
11. Role of miRNAs in immune responses and immunotherapy in cancer
    María Angélica Cortez, Simone Anfossi, Rishab Ramapriyan, Hari Menon, Semra Cemre Atalar, Maureen L. Aliru, James William Welsh, George A. Călin · 2018 · Genes Chromosomes and Cancer
12. Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival
    Hernando López-Bertoni, Kristen Kozielski, Yuan Rui, Bachchu Lal, Hannah J. Vaughan, David R. Wilson, Nicole Mihelson, Charles G. Eberhart, John Laterra, Jordan J. Green · 2018 · Nano Letters
13. RNA therapy: Are we using the right molecules?
    Ai‐Ming Yu, Chao Jian, Allan H. Yu, Mei‐Juan Tu · 2018 · Pharmacology & Therapeutics
14. miRNA dysregulation is an emerging modulator of genomic instability
    Ana P. Ferragut Cardoso, Mayukh Banerjee, Alexandra N. Nail, Angeliki Lykoudi, J. Christopher States · 2021 · Seminars in Cancer Biology
15. Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses.
    Duo Zhang, Heedoo Lee, Xiao-Yun Wang, A. Rai, Michael Groot, Yang Jin · 2018 · Molecular Therapy
16. MicroRNAs Contribute to Breast Cancer Invasiveness
    Ivana Fridrichová, Iveta Zmetakova · 2019 · Cells
17. Osteopontin -- a promising biomarker for cancer therapy
    Ran Wei, Janet Pik Ching Wong, Hang Fai Kwok · 2017 · Journal of Cancer
18. The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer
    Jesús Vallejo-Díaz, Mónica Chagoyen, Manuel Olazabal-Morán, Ana González-Garcı́a, Ana Clara Carrera · 2019 · Trends in cancer
19. How and Why Are Cancers Acidic? Carbonic Anhydrase IX and the Homeostatic Control of Tumour Extracellular pH
    Shen‐Han Lee, John R. Griffiths · 2020 · Cancers
20. Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
    Eleni Anastasiadou, Anita G. Seto, Xuan Beatty, Melanie Hermreck, Maud-Emmanuelle Gilles, Dina Stroopinsky, Lauren C. Pinter‐Brown, Linda A. Pestano, Cinzia Marchese, David Avigan et al. · 2020 · Clinical Cancer Research
21. MicroRNAs as Important Regulators of Exercise Adaptation
    Gustavo José Justo da Silva, Anja Bye, Hamid el Azzouzi, Ulrik Wisløff · 2017 · Progress in Cardiovascular Diseases
22. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo
    My-Anh Nguyen, Hailey Wyatt, Leah Susser, Michèle Geoffrion, Adil Rasheed, Anne‐Claire Duchez, Mary Lynn Cottee, Esther Afolayan, Eliya Farah, Zaina Kahiel et al. · 2019 · ACS Nano
23. Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone
    Muhammad Zakariyyah Aumeeruddy, Mohamad Fawzi Mahomoodally · 2019 · Cancer
24. Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
    Byungji Kim, Ryan Ramsey Hosn, Tanaka K. Remba, Dong Soo Yun, Na Li, Wuhbet D. Abraham, Mariane B. Melo, Manuel Cortés, Bridget Li, Yuebao Zhang et al. · 2022 · Journal of Controlled Release
25. Skeletal Muscle Wasting and Its Relationship With Osteoarthritis: a Mini-Review of Mechanisms and Current Interventions
    Emily Shorter, Anthony J. Sannicandro, B. Poulet, Katarzyna Goljanek‐Whysall · 2019 · Current Rheumatology Reports
26. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters
    Mariela Montaño-Samaniego, Diana M. Bravo‐Estupiñan, Oscar Méndez-Guerrero, Ernesto Alarcón-Hernández, Miguel Ángel Ibáñez-Hernández · 2020 · Frontiers in Oncology
27. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis
    Liangliang Ren, Han Chen, Junwei Song, Xuhong Chen, Chun‐Yu Lin, Xiaolan Zhang, Ning Hou, Jinyuan Pan, Zhongqiu Zhou, Lan Wang et al. · 2019 · Theranostics
28. The miRNA: a small but powerful RNA for COVID-19
    Song Zhang, Kuerbannisha Amahong, Xiuna Sun, Xichen Lian, Jin Liu, Huaicheng Sun, Yan Lou, Feng Zhu, Yunqing Qiu · 2021 · Briefings in Bioinformatics
29. Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
    Sadida, Hana Q., Abdulla, Alanoud, Marzooqi, Sara Al, Hashem, Sheema, Macha, Muzafar A., Akil, Ammira S. Al-Shabeeb, Bhat, Ajaz A. · 2024 · Translational Oncology
30. Modified nucleic acids: replication, evolution, and next-generation therapeutics
    Karen Duffy, Sebastian Arangundy‐Franklin, Philipp Holliger · 2020 · BMC Biology
31. The role of smooth muscle cells in plaque stability: Therapeutic targeting potential
    Jennifer Jill Harman, Helle Færk Jørgensen · 2019 · British Journal of Pharmacology
32. Editorial focus: understanding off-target effects as the key to successful RNAi therapy
    Rafał Bartoszewski, Aleksander F. Sikorski · 2019 · Cellular & Molecular Biology Letters
33. Serum exosomal micro RNA s combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
    Yurong Wang, Chunyan Zhang, Pengjun Zhang, Guanghong Guo, Tao Jiang, Xiumei Zhao, Jingjing Jiang, Xueliang Huang, Hongli Tong, Yaping Tian · 2018 · Cancer Medicine
34. An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage
    Yuqing Wang, Tengteng Shao, Jialin Wang, Xiaoting Huang, Xiaofei Deng, Yemin Cao, Mingmei Zhou, Cheng Zhao · 2020 · Biomedicine & Pharmacotherapy
35. Deciphering the tRNA-derived small RNAs: origin, development, and future
    Bowen Liu, Jinling Cao, Xiangyun Wang, Chunlei Guo, Yunxia Liu, Tianjiao Wang · 2021 · Cell Death and Disease
36. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis
    Caifeng Yue, Jierong Chen, Laisheng Li, Laisheng Li, Jugao Chen, Yun-Miao Guo · 2020 · Journal of Experimental & Clinical Cancer Research
37. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
    Zhen Zeng, Minyang Fu, Yuan Hu, Yuquan Wei, Xiawei Wei, Min Luo · 2023 · Molecular Cancer
38. Characterization of therapeutic oligonucleotides by liquid chromatography
    Alexandre Goyon, Peter Yehl, Kelly Zhang · 2020 · Journal of Pharmaceutical and Biomedical Analysis
39. MicroRNA: Dynamic Regulators of Macrophage Polarization and Plasticity
    Jezrom Self-Fordham, Afsar Raza Naqvi, Juhi Raju Uttamani, Varun Kulkarni, Salvador Nares · 2017 · Frontiers in Immunology
40. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target
    David J. Mellis, Andrea Caporali · 2017 · Biochemical Society Transactions
41. The Untranslated Regions of mRNAs in Cancer
    Samantha L. Schuster, Andrew Caleb Hsieh · 2019 · Trends in cancer
42. Recent advances in the synthesis techniques for zeolitic imidazolate frameworks and their sensing applications
    Preeti Kukkar, Ki‐Hyun Kim, Deepak Kukkar, Pritpal Singh · 2021 · Coordination Chemistry Reviews
43. Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in cancer
    Hui Wang, Liang Zou, Ke Ma, Jiankun Yu, Huizhe Wu, Minjie Wei, Qinghuan Xiao · 2017 · Molecular Cancer
44. Exploiting Exosomes in Cancer Liquid Biopsies and Drug Delivery
    Coy Austin Fitts, Nan Ji, Yusheng Li, Chalet Tan · 2019 · Advanced Healthcare Materials
45. Multiple myeloma: the (r)evolution of current therapy and a glance into future
    Annamaria Gullà, Kenneth Carl Anderson · 2020 · Haematologica
46. Ginger exosome-like nanoparticle-derived miRNA therapeutics: A strategic inhibitor of intestinal inflammation
    Ling Yan, Yaqi Cao, Linhai Hou, Tianyu Luo, Meiqi Li, Shengjie Gao, Lei Wang, Kangliang Sheng, Lei Zheng · 2024 · Journal of Advanced Research
47. Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors
    Andrew Dhawan, Jacob G. Scott, Adrian Llewellyn Harris, Francesca Meteora Buffa · 2018 · Nature Communications
48. Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B
    Hongliang Zhang, Jun Wang, Tingting Ren, Yi Huang, Xin Liang, Yiyang Yu, Wei Wang, Jianfang Niu, Wei Guo · 2020 · Cancer Letters
49. RNA‐based medicine: from molecular mechanisms to therapy
    Anke Sparmann, Jörg Vogel · 2023 · The EMBO Journal
50. Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo
    Yu‐Lin Su, Xiuli Wang, Mati Mann, Tomasz Adamus, Dongfang Wang, Dayson Moreira, Zhuoran Zhang, Ching Ouyang, Xin He, Bin Zhang et al. · 2019 · Blood
51. Nanomaterials for Therapeutic RNA Delivery
    Xuexiang Han, Michael J. Mitchell, Guangjun Nie · 2020 · Matter
52. Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis
    Yuqing Ren, Ruizhi Wang, Siyuan Weng, Hui Xu, Yuyuan Zhang, Shuang Chen, Shutong Liu, Yuhao Ba, Zhaokai Zhou, Peng Luo et al. · 2023 · Molecular Cancer
53. Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles
    Enping Hong, Justin R. Halman, Ankit B. Shah, Emil F. Khisamutdinov, Marina A. Dobrovolskaia, Kirill A. Afonin · 2018 · Nano Letters
54. Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology
    Andreas B. Gevaert, Jente R. A. Boen, Vincent F. M. Segers, Emeline M. Van Craenenbroeck · 2019 · Frontiers in Physiology
55. microRNA ‐based diagnostic and therapeutic applications in cancer medicine
    Lorenzo F. Sempere, Asfar Sohail Azmi, Anna V. Moore · 2021 · Wiley Interdisciplinary Reviews - RNA
56. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles
    Zahra Sadat Razavi, Vida Tajiknia, Shahab Majidi, Maryam Ghandali, Hamid Reza Mirzaei, Neda Rahimian, Michael Richard Hamblin, Hamed Mirzaei · 2020 · Critical Reviews in Oncology/Hematology
57. Dual Roles of Metal–Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy
    Huaixin Zhao, Taotao Li, Chi Yao, Zi Gu, Chunxia Liu, Jiahe Li, Dayong Yang · 2021 · ACS Applied Materials & Interfaces
58. Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer
    Hongbo Wang, Qinghai Meng, Jinjun Qian, Muxi Li, Chunyan Gu, Ye Yang · 2022 · Pharmacology & Therapeutics
59. Cancer-associated miRNAs and their therapeutic potential
    Jun Inoue, Johji Inazawa · 2021 · Journal of Human Genetics
60. Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics
    Kai K. Ewert, Pablo Scodeller, Lorena Simón‐Gracia, Victoria M. Steffes, Emily A. Wonder, Tambet Teesalu, Cyrus R. Safinya · 2021 · Pharmaceutics
61. The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
    Hannah Walgrave, Lujia Zhou, Bart De Strooper, Evgenia Salta · 2021 · Molecular Neurodegeneration
62. Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review
    Francesco Nappi · 2024 · International Journal of Molecular Sciences
63. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1
    Shengni Hua, Ling Lei, Ling Deng, Xie Weng, Chengdong Liu, Xiaolong Qi, Shuang Wang, Dongyan Zhang, Xuejing Zou, Chuanhui Cao et al. · 2018 · Oncogene
64. Graph convolution for predicting associations between miRNA and drug resistance
    Yu‐An Huang, Pengwei Hu, Keith C. C. Chan, Zhu‐Hong You · 2019 · Bioinformatics
65. A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis
    Chioccioli, Maurizio, Roy, Subhadeep, Newell, Rachel, Pestano, Linda, Dickinson, Brent, Rigby, Kevin, Herazo-Maya, Jose, Jenkins, Gisli, Ian, Steward, Saini, Gauri et al. · 2022 · eBioMedicine
66. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
    Qiaozhu Su, Virender Kumar, Neetu Sud, Ram I. Mahato · 2018 · Advanced Drug Delivery Reviews
67. Injectable “nano-micron” combined gene-hydrogel microspheres for local treatment of osteoarthritis
    Bin Li, Fei Wang, Fangqiong Hu, Tao Ding, Ping Huang, Xing Yue Xu, Jing Liang, Changwei Li, Qi Zhou, Min Lu et al. · 2022 · NPG Asia Materials
68. Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Mengke Niu, Ming Yi, Ning Li, Suxia Luo, Kongming Wu · 2021 · Experimental Hematology and Oncology
69. Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities
    Stephanie M. Ryan, Ramon M. Eichenberger, Roland Ruscher, Paul Giacomin, Alex C. Loukas · 2020 · PLoS Pathogens
70. Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry
    Peipei Wang, Yue Zhou, Mark Richards · 2021 · Theranostics
71. RNA therapeutics: updates and future potential
    Caroline Zhang, Biliang Zhang · 2022 · Science China Life Sciences
72. Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns
    M. Xue, Ruilong Zhao, Hai-Yan Lin, C. Jackson · 2018 · Advanced Drug Delivery Reviews
73. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
    Jorge Luis Torres, Ignacio Novo‐Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, F.J. Laso, Miguel Marcos · 2018 · World Journal of Gastroenterology
74. Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
    Vera Miranda‐Gonçalves, Ana Lameirinhas, Rui Henrique, Cármen Jerónimo · 2018 · Frontiers in Genetics
75. CircRNAs in anticancer drug resistance: recent advances and future potential
    Tianwei Xu, Mengwei Wang, Lihua Jiang, Li Ma, Li Wan, Qinnan Chen, Chenchen Wei, Zhaoxia Wang · 2020 · Molecular Cancer
76. Sustained delivery of MMP-9 siRNA via thermosensitive hydrogel accelerates diabetic wound healing
    Biyun Lan, Liming Zhang, Liqun Yang, Junfeng Wu, Na Li, Chenglin Pan, Xiaoyi Wang, Lexiang Zeng, Yan Li, Chuan He Yang et al. · 2021 · Journal of Nanobiotechnology
77. A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1α and p53 activity in triple-negative breast cancer
    Ye Du, Na Wei, Ruolin Ma, Shu‐Heng Jiang, Dong Song · 2020 · Cell Death and Disease
78. Nucleic acid delivery with extracellular vesicles
    Michaela Schulz‐Siegmund, Achim Michael Aigner · 2021 · Advanced Drug Delivery Reviews
79. A bioswitchable delivery system for microRNA therapeutics based on a tetrahedral DNA nanostructure
    Songhang Li, Taoran Tian, Tao Zhang, Yunfeng Lin, Xiaoxiao Cai · 2024 · Nature Protocols
80. Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation
    Ahmed Mahas, C. Neal Stewart, Magdy M. Mahfouz · 2017 · Biotechnology Advances
81. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks
    Naghmeh Shirafkan, Behzad Mansoori, Ali Mohammadi, Navid Shomali, Mehri Ghasbi, Behzad Baradaran · 2017 · Biomedicine & Pharmacotherapy
82. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines
    Nakamura, Takashi, Sato, Yusuke, Yamada, Yuma, Abd Elwakil, Mahmoud M., Kimura, Seigo, Younis, Mahmoud A., Harashima, Hideyoshi · 2022 · Advanced Drug Delivery Reviews
83. Advances in MicroRNA Therapeutics: From Preclinical to Clinical Studies
    Simona Brillante, Mariagrazia Volpe, Alessia Indrieri · 2024 · Human Gene Therapy
84. Cognitive dysfunction: a growing link between diabetes and Alzheimer’s disease
    Jash, Kavya, Gondaliya, Piyush, Kirave, Prathibha, Kulkarni, Bhagyashri, Sunkaria, Aditya, Kalia, Kiran · 2020 · Drug Development Research
85. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway
    Shoukun Ding, Donghai Liu, Lixia Wang, Guanggong Wang, Yaobin Zhu · 2019 · Journal of Pharmacology and Experimental Therapeutics
86. Towards extracellular matrix normalization for improved treatment of solid tumors
    Hoda Soleymani Abyaneh, Maximilian Regenold, Trevor D. McKee, Christine J. Allen, Marc Andre Gauthier · 2020 · Theranostics
87. Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB
    Zuotian Huang, Tong Mou, Yunhai Luo, Xingyu Pu, Junliang Pu, Lei Wan, Junhua Gong, Hang Yang, Yanyao Liu, Zhongtang Li et al. · 2020 · Cell Death and Disease
88. Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity
    Alex Cleber Improta Caria, Carolina Kymie Vasques Nonaka, Ciro Silveira Pereira, Milena Botelho Pereira Soares, Simone Garcia Macambira, Bruno Solano de Freitas Souza · 2018 · International Journal of Molecular Sciences
89. MicroRNA-125b-5p regulates IL-1β induced inflammatory genes via targeting TRAF6-mediated MAPKs and NF-κB signaling in human osteoarthritic chondrocytes
    Z. Rasheed, Naila Rasheed, W. Al Abdulmonem, M. I. Khan · 2019 · Scientific Reports
90. The role of miR-200 family in the regulation of hallmarks of cancer
    Klaudia Klicka, Tomasz M. Grzywa, Aleksandra Mielniczuk, Alicja Klinke, Pawel Krzysztof Wlodarski · 2022 · Frontiers in Oncology
91. MicroRNAs and immunity in periodontal health and disease
    Xianghong Luan, Xiaofeng C. Zhou, Afsar Raza Naqvi, Marybeth Francis, Deborah Foyle, Salvador Nares, Thomas G.H. Diekwisch · 2018 · International Journal of Oral Science
92. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair–Deficient Colorectal Cancer by Targeting PD-L1
    Mai Ashizawa, Hirokazu Okayama, Teruhide Ishigame, Aung Kyi Thar Min, Katsuharu Saito, Daisuke Ujiie, Yuko Murakami, Tomohiro Kikuchi, Yuko Nakayama, Masaru Noda et al. · 2019 · Molecular Cancer Research
93. Current RNA-based Therapeutics in Clinical Trials
    Lingyan Zhou, Zhou Qin, Yanghui Zhu, Zhiyao He, Ting Xu · 2019 · Current Gene Therapy
94. Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
    Ralf‐Peter Czekay, Dong‐Joo Cheon, Rohan Samarakoon, Stacie M. Kutz, Paul J. Higgins · 2022 · Cancers
95. Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer
    Weihong Ren, XuRan Zhang, WenBo Li, Qian Feng, Huijie Feng, Yan Tong, Hao Rong, Wei Wang, Dai Zhang, Zhenqiang Zhang et al. · 2019 · Cancer Management and Research
96. MiRNAs and Cancer: Key Link in Diagnosis and Therapy
    Yu Shi, Zihao Liu, Qun Lin, Qing Luo, Yinghuan Cen, Juanmei Li, Xiaolin Fang, Chang Gong · 2021 · Genes
97. The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
    Elham Oveili, Somayeh Vafaei, Haniyeh Bazavar, Yeganeh Eslami, Ehsan Mamaghanizadeh, Saman Yasamineh, Omid Gholizadeh · 2023 · Cell Communication and Signaling
98. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets
    Yishay Pinto, Ilana Buchumenski, Erez Y. Levanon, Eli Eisenberg · 2017 · Nucleic Acids Research
99. Intracellular Nonenzymatic In Situ Growth of Three-Dimensional DNA Nanostructures for Imaging Specific Biomolecules in Living Cells
    Ran Liu, Songbai Zhang, Tingting Zheng, Yan-Ru Chen, Jingting Wu, Zai‐Sheng Wu · 2020 · ACS Nano
100. Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128
     Feng He, Zhi Song, Huacui Chen, Zhuanpeng Chen, Ping Yang, Wanglin Li, Zhi Huai Yang, Tong Zhang, Fei Wang, Jianchang Wei et al. · 2018 · Oncogene